Hypovolemic Shock
17
2
2
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
90.9%
+4.3% vs benchmark
24%
4 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (17)
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Digital Escape Room Game for Hypovolemic Shock Management
Efficacy of Prehospital Tourniquet Models for Arterial Occlusion in Upper and Lower Limbs
Early Initiated Vasopressor Therapy in the Emergency Department
Digital Ischemia Reduction in Critically Ill Patients
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Evaluation of Resuscitation Markers in Trauma Patients
Inferior Vena Cava Assessment in Term Pregnancy Using Ultrasound: a Feasibility Study of Subxiphoid and RUQ Views
Kinetics of the Sublingual Microcirculation During Fluid Bolus
Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis
Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery
Renal Resistive Index in Patients With Shock
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage: Zambia and Zimbabwe
Hemodynamic Measurements at Different Inclinations of the Head
Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt